VEGFD and Alzheimer disease: Pathways associated with receptor and ligand binding/signaling, including vascular endothelial growth factor receptor binding (p = 3.21x10−4), were distinctive to AD and predominantly driven by VEGFD and VEGFA (Supplementary Fig. 7).